Evidence map›Paper›PMID 36988578›Full record

ArticleMicrobial genomics2023

Travel-associated lineages and unique endemic antimicrobial-susceptible lineages of

Barakat A Al Suwayyid, Ethan C Haese, Shakeel Mowlaboccus, Julie C Pearson, David M Whiley, Paul K Armstrong, Carolien M Giele, Donna B Mak, Lisa Bastian, Michael J Wise and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbial genomics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Barakat A Al SuwayyidThe Marshall Centre for Infectious Diseases Research and Training, School of Biomedical Sciences, The University of Western Australia, Crawley, Australia.
Ethan C HaeseThe Marshall Centre for Infectious Diseases Research and Training, School of Biomedical Sciences, The University of Western Australia, Crawley, Australia.
Shakeel MowlaboccusThe Marshall Centre for Infectious Diseases Research and Training, School of Biomedical Sciences, The University of Western Australia, Crawley, Australia.
Julie C PearsonDepartment of Microbiology, PathWest Laboratory Medicine-WA, Fiona Stanley Hospital, Murdoch, Australia.
David M WhileyThe University of Queensland Centre for Clinical Research (UQ-CCR), Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
Paul K ArmstrongCommunicable Disease Control Directorate, Department of Health Western Australia, Perth, Australia.
Carolien M GieleCommunicable Disease Control Directorate, Department of Health Western Australia, Perth, Australia.
Donna B MakCommunicable Disease Control Directorate, Department of Health Western Australia, Perth, Australia.
Lisa BastianCommunicable Disease Control Directorate, Department of Health Western Australia, Perth, Australia.
Michael J WiseThe Marshall Centre for Infectious Diseases Research and Training, School of Biomedical Sciences, The University of Western Australia, Crawley, Australia.
Geoffrey W CoombsAntimicrobial Resistance and Infectious Diseases Research Laboratory, Murdoch University, Murdoch, Australia.
Charlene M KahlerThe Marshall Centre for Infectious Diseases Research and Training, School of Biomedical Sciences, The University of Western Australia, Crawley, Australia.
Government of Western Australia Department of Health · AUThe University of Western Australia · AUMurdoch University · AUFiona Stanley Hospital · AUThe Kids Research Institute Australia · AUThe University of Queensland · AU

Funding

Wellcome Trust
6 · The paper itself

Abstract

In Australia, gonococcal isolates are monitored for antimicrobial susceptibilities. In Western Australia (WA), gonorrhoea notification rates increased by 63 % between 2013 and 2016, with the steepest increase occurring between 2015 and 2016, before stabilizing at this higher baseline between 2017 and 2020. This increased prevalence was associated with antimicrobial-susceptible (AMS) lineages. To understand the provenance of these isolates causing gonorrhoea in WA, whether they were introduced or expanded from endogenous lineages, 741 isolates were collected in 2017 and characterized by both iPLEX typing and whole genome sequencing (WGS). Antibiograms and genocoding of the isolates revealed that AMS isolates were most prevalent in the remote regions, while the urban/rural regions were characterized by antimicrobial-resistant (AMR) isolates. iPLEX typing identified 78 iPLEX genotypes (WA-1 to WA-78) of which 20 accounted for over 88 % of isolates. WA-10 was the most frequently identified genotype in the urban/rural regions whilst WA-29 was the most frequently identified genotype in the remote regions. Genotypes WA-38, WA-52 and WA-13 accounted for 81 % (

Indexed as

Anti-Infective AgentsGonorrheaAnti-Bacterial AgentsAzithromycinBayes TheoremHumansMolecular EpidemiologyMultilocus Sequence TypingNeisseria gonorrhoeaeTravelWestern AustraliaAnti-Bacterial AgentsAnti-Infective AgentsAzithromycinantimicrobial resistancegonococcal epidemiologyiPLEXMLSTNG-STAR

Identifiers

PMID36988578
PMCPMC10132056
OpenAlexW4361287068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.